Formation of Provider Network Holdings Unites Altus Biologics, Remedy GPO, Cornerstone Specialty Network, and Health Coalition to Empower Specialty Providers and Supply Chain Stakeholders
Formation of Provider Network Holdings Unites Altus Biologics, Remedy GPO, Cornerstone Specialty Network, and Health Coalition to Empower Specialty Providers and Supply Chain Stakeholders
The formation of PNH extends the breadth of ways each organization can service clients while also providing a meaningful opportunity to enter adjacent therapeutic areas in the $300B+ specialty medication market.PEARLAND, Texas, April 10, 2024 /PRNewswire/ -- The formation of Provider Network Holdings ("PNH") was announced today through the partnership and combination of Altus Biologics ("Altus"), Remedy GPO ("Remedy"), Cornerstone Specialty Network ("Cornerstone"), and Health Coalition Inc. ("Health Coalition"). The combination enables the new platform to reach a broader network of specialty providers across community-based oncology, neurology, rheumatology, gastroenterology, allergy, immunology, pulmonary, and infectious disease practices. These four innovative and market leading organizations are committed to the mission of supporting independent specialty practices and providers throughout the country with technology, tools and services for specialty and biologic drug purchasing, supply chain, revenue cycle management, education, and research. Together, the combined organization will support over 1,500 physicians across 41 states.
得克萨斯州皮尔兰，2024年4月10日 /PRNewswire/ — 今天宣布通过Altus Biologics（“Altus”）、Remedy GPO（“Remedy”）、Cornerstone Specialty Network（“Cornerstone”）和健康联盟公司（“健康联盟”）的合作和合并，成立提供商网络控股公司（“PNH”）。此次合并使新平台能够覆盖更广泛的专业提供者网络，涵盖社区肿瘤学、神经病学、风湿病学、胃肠病学、过敏、免疫学、肺部和传染病诊所。这四个具有创新精神和市场领先地位的组织致力于为全国各地的独立专业诊所和提供商提供支持，为特种和生物药物采购、供应链、收入周期管理、教育和研究提供商提供技术、工具和服务。合并后的组织将共同为41个州的1,500多名医生提供支持。
Altus is a leading provider of comprehensive supply chain services for biologic and specialty medication management, as well as in-office infusion management services. Remedy operates a group purchasing organization and offers value-added services that are responsive to both specialty providers and pharmaceutical partners' needs. Cornerstone is the largest independent community oncology network, delivering aggregated value-based offerings, educational resources, research, and data services. Health Coalition is a specialty and biologic pharmaceutical distributor with value-added capabilities serving manufacturers and providers. Together with the backing of Waud Capital Partners ("WCP"), a healthcare-focused private equity firm, PNH will offer a continuum of essential and differentiated products and solutions for a variety of specialty and biologic drug needs. PNH will also serve as a value-add partner to pharmaceutical manufacturers and wholesalers, while also working to build a broader suite of supply chain services and improve provider engagement.
Altus 是生物制剂和特种药物管理综合供应链服务以及办公室内输液管理服务的领先提供商。Remedy 经营团体采购组织，提供增值服务，以满足专业提供商和制药合作伙伴的需求。Cornerstone是最大的独立社区肿瘤学网络，提供基于价值的综合产品、教育资源、研究和数据服务。Health Coalition是一家专业和生物制药分销商，具有为制造商和提供商提供服务的增值能力。在专注于医疗保健的私募股权公司Waud Capital Partners（“WCP”）的支持下，PNH将为各种特种和生物药物需求提供一系列基本和差异化的产品和解决方案。PNH还将成为药品制造商和批发商的增值合作伙伴，同时还将努力建立更广泛的供应链服务并提高提供商的参与度。
David Lowenberg, Chairman of PNH and WCP Operating Partner, expressed enthusiasm about the combination of Altus, Remedy, Cornerstone, and Health Coalition within PNH. He commented, "We are pleased to unite these four highly valuable organizations, aligning our commitment to bolster value-added performance and enhance efficiency. This confluence of tailored offerings for the distinctive challenges faced by physician practices and providers creates an end-to-end solutions provider for the specialty and biologic drug market."
PNH主席兼WCP运营合作伙伴大卫·洛文伯格对PNH内部Altus、Remedy、Cornerstone和Health Coalition的合并表示热情。他评论说：“我们很高兴将这四个极具价值的组织联合起来，协调我们对提高增值绩效和提高效率的承诺。这种针对医生诊所和提供商面临的独特挑战的量身定制产品的融合为特种和生物药物市场创造了端到端的解决方案提供商。”
The formation of PNH extends the breadth of ways each organization can service clients while also providing a meaningful opportunity to enter adjacent therapeutic areas in the $300B+ specialty medication market.
PNH的成立扩大了每个组织为客户提供服务的方式的广度，同时也为进入3000亿美元以上的特种药物市场中的邻近治疗领域提供了有意义的机会。
"We built Cornerstone to empower practices with the advantages of scale while protecting their independence and fuel meaningful customer engagement for our manufacturer partners," said Joel Schaedler, CEO of Cornerstone, who will continue leading the business as part of PNH. "I am excited to thoughtfully expand the relevant portfolio of services we can offer to our diversified, purpose-built network as part of Provider Network Holdings."
作为PNH的一部分，Cornerstone首席执行官乔尔·舍德勒表示：“我们建立Cornerstone的目的是让业务部门发挥规模优势，同时保护其独立性，促进制造商合作伙伴的有意义的客户参与。”“作为提供商网络控股的一部分，我很高兴能够深思熟虑地扩大我们可以为我们的多元化、专门构建的网络提供的相关服务组合。”
Walter Shikany III, President of Health Coalition, commented, "Health Coalition partners with specialty pharmaceutical manufacturers to educate, distribute, and service an expansive and decentralized network of providers requiring a high-touch approach. We are thrilled for this next chapter in Health Coalition's over 35 years of finding the best solutions for the unique challenges each practice faces."
健康联盟主席沃尔特·希卡尼三世评论说：“健康联盟与特种药品制造商合作，对需要高接触方法的庞大而分散的提供商网络进行教育、分销和服务。我们对健康联盟35年来为每家诊所面临的独特挑战寻找最佳解决方案的下一个篇章感到非常兴奋。”
About Provider Network Holdings
关于提供商网络控股
Provider Network Holdings supports a deep network of over 1,500 provider partners across multiple physician specialties with a comprehensive suite of practice management, supply chain, group purchasing, and pharmaceutical solutions for specialty and biologic drug needs. Proprietary technology, data analytics, and unique clinical positioning enable Provider Network Holdings to create custom programs and breakthrough offerings that address the evolving landscape across specialty providers, pharmaceutical manufacturers, and wholesalers. To learn more, visit .
Provider Network Holdings为涵盖多个医师专业的1,500多家提供商合作伙伴的深度网络提供支持，为满足特种和生物药物需求的全套执业管理、供应链、团体采购和药物解决方案提供支持。专有技术、数据分析和独特的临床定位使Provider Network Holdings能够创建定制计划和突破性产品，以应对专业提供商、药品制造商和批发商不断变化的格局。要了解更多信息，请访问。
About Waud Capital Partners
关于沃德资本合伙人
Based in Chicago, Waud Capital Partners ("WCP") is a growth-oriented private equity firm with over 30 years of investing experience. WCP seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, WCP has successfully completed more than 460 investments, including platform companies and follow-on opportunities. For additional information on WCP, please visit .
Waud Capital Partners（“WCP”）总部位于芝加哥，是一家以增长为导向的私募股权公司，拥有超过30年的投资经验。WCP寻求与经验丰富的管理团队合作，在两个行业中建立市场领先的公司：医疗保健和软件与技术。自1993年成立以来，WCP已成功完成了460多项投资，包括平台公司和后续机会。有关 WCP 的更多信息，请访问。
Provider Network Holdings Contact:
[email protected]
提供商网络控股联系人：
[电子邮件保护]
WCP Investment Professional Contact:
Tim Cremieux, Principal
[email protected]
WCP 投资专业人员联系方式：
蒂姆·克雷米厄斯，校长
[电子邮件保护]
WCP Business Development Contact:
Phil Olson, Partner
[email protected]
WCP 业务开发联系人：
菲尔·奥尔森，合伙人
[电子邮件保护]
WCP Investor Relations Contact:
Matt Albers, Partner
[email protected]
WCP 投资者关系联系人：
马特·阿尔伯斯，合伙人
[电子邮件保护]
SOURCE Waud Capital Partners
来源沃德资本合伙人
